Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

被引：30

作者：

Yatim, Nader ^{[1
,2
]}

Boussier, Jeremy ^{[3
]}

Tetu, Pauline ^{[2
]}

Smith, Nikaia ^{[1
]}

Bruel, Timothee ^{[4
,5
]}

Charbit, Bruno ^{[6
]}

Barnabei, Laura ^{[7
]}

Corneau, Aurelien ^{[8
]}

Da Meda, Laetitia ^{[2
]}

Allayous, Clara ^{[2
]}

Baroudjian, Barouyr ^{[2
]}

Jebali, Majdi ^{[2
]}

Herms, Florian ^{[2
]}

Grzelak, Ludivine ^{[4
]}

Staropoli, Isabelle ^{[4
]}

Calmettes, Vincent ^{[9
]}

Hadjadj, Jerome ^{[7
,10
]}

Peyrony, Olivier ^{[11
]}

Cassius, Charles ^{[2
]}

LeGoff, Jerome ^{[12
]}

Kramkimel, Nora ^{[9
]}

Aractingi, Selim ^{[9
]}

Fontes, Magnus ^{[13
]}

Blanc, Catherine ^{[8
]}

Rieux-Laucat, Frederic ^{[7
]}

Schwartz, Olivier ^{[4
,5
]}

Terrier, Benjamin ^{[10
]}

Duffy, Darragh ^{[1
,6
]}

Lebbe, Celeste ^{[2
]}

机构：

[1] Inst Pasteur, Dept Immunol, Translat Immunol Lab, F-75015 Paris, France

[2] Univ Paris, Hop St Louis, AP HP, DMU ICARE,INSERM U 976,Dermatol Dept, Paris, France

[3] Sorbonne Univ, Hop St Antoine, AP HP, F-75012 Paris, France

[4] CNRS, Inst Pasteur, Dept Virol, Virus & Immun Unit,UMR 3569, Paris, France

[5] Vaccine Res Inst, Creteil, France

[6] Inst Pasteur, Cytometry & Biomarkers UTechS, CRT, F-75015 Paris, France

[7] Univ Paris, INSERM, Lab Immunogenet Pediatr Autoimmune Dis, Imagine Inst,UMR 1163, F-75015 Paris, France

[8] Sorbonne Univ, Fac Med, Plateforme Cytometrie Pitie Salpetriere CyPS, PASS,UMS037, F-75013 Paris, France

[9] Univ Paris, Hop Cochin, AP HP, Dept Dermatol, Paris, France

[10] Univ Paris, Hop Cochin, AP HP, Ctr APHP CUP,Dept Internal Med,Natl Referral Ctr, F-75014 Paris, France

[11] Hop St Louis, AP HP, Emergency Dept, Paris, France

[12] Univ Paris, Hop St Louis, AP HP, Equipe INSIGHT,U976,Virol,INSERM, F-75010 Paris, France

[13] Inst Roche, Boulogne, France

来源：

SCIENCE ADVANCES | 2021年 / 7卷 / 34期

关键词：

COVID-19; CANCER; SEPSIS; SAFETY;

D O I：

10.1126/sciadv.abg4081

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The COVID-19 pandemic has spread worldwide, yet the role of antiviral T cell immunity during infection and the contribution of immune checkpoints remain unclear. By prospectively following a cohort of 292 patients with melanoma, half of which treated with immune checkpoint inhibitors (ICIs), we identified 15 patients with acute or convalescent COVID-19 and investigated their transcriptomic, proteomic, and cellular profiles. We found that ICI treatment was not associated with severe COVID-19 and did not alter the induction of inflammatory and type I interferon responses. In-depth phenotyping demonstrated expansion of CD8 effector memory T cells, enhanced T cell activation, and impaired plasmablast induction in ICI-treated COVID-19 patients. The evaluation of specific adaptive immunity in convalescent patients showed higher spike (S), nucleoprotein (N), and membrane (M) antigen-specific T cell responses and similar induction of spike-specific antibody responses. Our findings provide evidence that ICI during COVID-19 enhanced T cell immunity without exacerbating inflammation.

引用

页数：13

共 50 条

[1] Immune checkpoint inhibitors and SARS-CoV2 infection
Abdolmohammadi-Vahid, Samaneh
Baradaran, Behzad
Adcock, Ian M.
Mortaz, Esmaeil
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
[2] T cell immunity to SARS-CoV-2
Niessl, Julia
Sekine, Takuya
Buggert, Marcus
SEMINARS IN IMMUNOLOGY, 2021, 55
[3] Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection
Sharif-Askari, Narjes Saheb
Sharif-Askari, Fatemeh Saheb
Mdkhana, Bushra
Al Heialy, Saba
Alsafar, Habiba S.
Hamoudi, Rifat
Hamid, Qutayba
Halwani, Rabih
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 109 - 121
[4] T cell immunity to SARS-CoV-2 following natural infection and vaccination
DiPiazza, Anthony T.
Graham, Barney S.
Ruckwardt, Tracy J.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 211 - 217
[5] Immunity to SARS-CoV-2 infection
Pepper, Marion
IMMUNOLOGICAL REVIEWS, 2022, 309 (01) : 5 - 7
[6] SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
Ahmad, Rahnuma
BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2021, 20 : S32 - S40
[7] Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and ?? T cell perturbations
Habel, Jennifer R.
Chua, Brendon Y.
Kedzierski, Lukasz
Selva, Kevin J.
Damelang, Timon
Haycroft, Ebene R.
Nguyen, Thi H. O.
Koay, Hui-Fern
Nicholson, Suellen
McQuilten, Hayley A.
Jia, Xiaoxiao
Allen, Lilith F.
Hensen, Luca
Zhang, Wuji
Sandt, Carolien E. van de
Neil, Jessica A.
Pragastis, Katherine
Lau, Jillian S. Y.
Jumarang, Jaycee
Allen, E. Kaitlynn
Amanant, Fatima
Krammer, Florian
Wragg, Kathleen M.
Juno, Jennifer A.
Wheatley, Adam K.
Tan, Hyon-Xhi
Pell, Gabrielle
Walker, Susan
Audsley, Jennifer
Reynaldi, Arnold
Thevarajan, Irani
Denholm, Justin T.
Subbarao, Kanta
Davenport, Miles P.
Hogarth, P. Mark
Godfrey, Dale I.
Cheng, Allen C.
Tong, Steven Y. C.
Bond, Katherine
Williamson, Deborah A.
McMahon, James H.
Thomas, Paul G.
Pannaraj, Pia S.
James, Fiona
Holmes, Natasha E.
Smibert, Olivia C.
Trubiano, Jason A.
Gordon, Claire L.
Chung, Amy W.
Whitehead, Clare L.
JCI INSIGHT, 2023, 8 (06)
[8] SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
Pitiriga, Vassiliki C.
Papamentzelopoulou, Myrto
Konstantinakou, Kanella E.
Theodoridou, Kalliopi
Vasileiou, Irene V.
Tsakris, Athanasios
VACCINES, 2023, 11 (07)
[9] Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
Gambichler, Thilo
Reuther, Judith
Scheel, Christina H.
Susok, Laura
Kern, Peter
Becker, Jurgen C.
CANCERS, 2020, 12 (11) : 1 - 14
[10] SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
Yang Yang
Gaosi Xu
Cell Death & Disease, 14

← 1 2 3 4 5 →